Claims for Patent: 5,869,127

Summary for Patent: 5,869,127

Title:	Method of providing a substrate with a bio-active/biocompatible coating
Abstract:	Disclosed is a method of enhancing the biocompatibility of a substrate by providing the substrate with a continuous bio-active surface coating. This method includes applying to the substrate a first coating which includes an aqueous dispersion or emulsion of a polymer containing an organic acid functional group and an excess of a polyfunctional cross-linking agent which is reactive with the organic acid groups of the polymer. A continuous bio-active surface coating is then formed over the dried first coating by applying thereover a bio-active agent containing an organic acid functional group or metal salt thereof. The first and second coatings are then dried to covalently bond the organic acid functional groups of the bio-active agent to the polymer through the excess unreacted polyfunctional cross-linking agent.
Inventor(s):	Zhong; Sheng-Ping (Northboro, MA)
Assignee:	Boston Scientific Corporation (Natick, MA)
Application Number:	08/877,825
Patent Claims:	1. A method of enhancing the biocompatibility of a substrate by providing said substrate with a continuous bio-active surface coating comprising: a) applying to said substrate a first coating comprising an aqueous dispersion or emulsion of (i) a polymer containing an organic acid functional group and (ii) an excess of a polyfunctional cross-linking agent which is reactive with said organic acid groups of said polymer, permitting said first coating to dry in order to cross-link and render said first coating substantially water-insoluble, wherein unreacted polyfunctional cross-linking agent remains present in said cross-linked first coating; b) forming said continuous bio-active surface coating on said substrate by contacting said dried first coating layer with a second coating of an aqueous solution or dispersion of a bio-active agent containing an organic acid functional group or metal salt thereof; and c) drying said first and second coatings to covalently bond said organic acid functional groups of said bio-active agent to said polymer through said excess unreacted polyfunctional cross-linking agent. 2. The method of claim 1, wherein said organic acid functional groups of said polymer and said bio-active agent are independently selected from the group consisting of free carboxylic acid, free sulfonic acid, free phosphoric acid, and combinations thereof. 3. The method of claim 1, wherein said metal salts are alkali metal salts and quaternary amine salts. 4. The method of claim 1, wherein said polyfunctional cross-linking agent has more than two functional groups per molecule. 5. The method of claim 1, wherein said polymer is one of an organic acid functional group-containing homo- and copolymer. 6. The method of claim 1, wherein said polymer is selected from the group consisting of polyurethanes, polyacrylates, poly(meth)acrylates, polyisocrotonates, epoxy resins, (meth)acrylate-urethane copolymers and combinations thereof. 7. The method of claim 1, wherein said polymer is an (meth)acrylate-urethane copolymer. 8. The method of claim 1, wherein said polymer is a polyurethane. 9. The method according to claim 1, wherein said bio-active agent is selected from the group consisting of anti-thrombogenic agents, antibiotic agents, anti-tumor agents, antiviral agents, anti-angiogenic agents, angiogenic agents, anti-mitotic agents, anti-inflammatory agents, angiostatin agents, endostatin agents, cell cycle regulatory agents, genetic agents, growth hormones and mixtures thereof. 10. The method according to claim 1, wherein said bio-active agent is an organic acid functional group-containing polysaccharide. 11. The method according to claim 10, wherein said polysaccharide is a glycosaminoglycan. 12. The method according to claim 11, wherein said glycosaminoglycan is selected from the group consisting of heparin, hirudin, heparin sulfate, hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratin sulfate, prostoctein, reopro, integrin and chemically-modified equivalents thereof. 13. The method according to claim 1, wherein the concentration of said polymer in said first coating is from about 1% to about 60% by weight solids content. 14. The method according to claim 1, wherein the concentration of said polymer in said first coating is from about 1% to about 40% by weight solids content. 15. The method according to claim 1, wherein the concentration of said polyfunctional cross-linking agent in said first coating is from about 0.2% to about 40% by weight solids content of said first coating. 16. The method according to claim 1, wherein said first layer is covalently bonded to said second layer via said polyfunctional cross-linking agent at a temperature below about 120.degree. C. 17. The method according to claim 1, wherein said first layer is covalently bonded to said second layer via said polyfunctional cross-linking agent at a temperature between about 10.degree. C. and about 70.degree. C.

Details for Patent 5,869,127

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	REOPRO	abciximab	Injection	103575	12/22/1994		2015-02-22